Stryker

Stryker corporation manufactures several modular implant component systems used during total hip arthroplasty (THR). However, the company issued least three different Stryker hip replacement recalls over the last decade. Patients reported issues ranging from premature hip failure to metallosis, forcing them to undergo expensive and painful revision surgeries.

In the past, Stryker agreed to pay $1.43 billion to settle claims related to the following modular hip implants:

More recently, the manufacturer voluntarily recalled its LFIT CoCr V40 Femoral Heads. All three recalls involved metal-on-metal (MoM) implants, which the FDA warns may corrode over time. When MoM components grind against one another, they release microscopic metal fragments into your bloodstream. Eventually, these metal ions kill off soft tissue surrounding the artificial hip joint and lead to blood metal poisoning, which may be fatal. Patients are suing for a range of injuries, including hip joint failure, amputations and even death.